Cargando…
Selective purging of human multiple myeloma cells from peripheral blood mononuclear cells: a preliminary study
BACKGROUND: High-dose chemotherapy followed by autologous peripheral blood stem-cell transplantation are standards of therapy for patients diagnosed with multiple myeloma. The purging process to remove contaminating residual myeloma cells could improve patient outcomes. In this study, a purging meth...
Autores principales: | Lee, A-Jin, Kim, Sang-Gyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469481/ https://www.ncbi.nlm.nih.gov/pubmed/31043801 http://dx.doi.org/10.2147/JBM.S193467 |
Ejemplares similares
-
Molecular purging of multiple myeloma cells by ex-vivo culture and retroviral transduction of mobilized-blood CD34(+ )cells
por: Deola, Sara, et al.
Publicado: (2007) -
Usefulness of Lymphokine‐activated Killer Cells Generated from Bone Marrow Mononuclear Cells for the Purging of Residual Tumor Cells in Peripheral Blood Stem Cell Graft
por: Komatsu, Fumio, et al.
Publicado: (1996) -
An immunotoxin containing momordin suitable for bone marrow purging in multiple myeloma patients.
por: Dinota, A., et al.
Publicado: (1989) -
The DNA Methylome of Human Peripheral Blood Mononuclear Cells
por: Li, Yingrui, et al.
Publicado: (2010) -
purgeR: inbreeding and purging in pedigreed populations
por: López-Cortegano, Eugenio
Publicado: (2021)